ORLACCHIO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 3.929
EU - Europa 2.791
AS - Asia 1.581
Continente sconosciuto - Info sul continente non disponibili 37
SA - Sud America 6
AF - Africa 2
OC - Oceania 1
Totale 8.347
Nazione #
US - Stati Uniti d'America 3.905
IE - Irlanda 1.115
SG - Singapore 559
VN - Vietnam 520
IT - Italia 474
FI - Finlandia 297
HK - Hong Kong 266
RU - Federazione Russa 252
CN - Cina 154
UA - Ucraina 118
SE - Svezia 108
FR - Francia 83
AT - Austria 70
DE - Germania 51
GB - Regno Unito 47
PL - Polonia 45
EU - Europa 36
RO - Romania 30
KR - Corea 29
CH - Svizzera 28
CA - Canada 23
NL - Olanda 22
UZ - Uzbekistan 16
GR - Grecia 14
BE - Belgio 13
JP - Giappone 13
CZ - Repubblica Ceca 10
LB - Libano 8
TR - Turchia 7
DK - Danimarca 6
MY - Malesia 5
SK - Slovacchia (Repubblica Slovacca) 4
BR - Brasile 3
CL - Cile 3
ES - Italia 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
PH - Filippine 1
TW - Taiwan 1
Totale 8.347
Città #
Dublin 1.110
San Mateo 675
Dong Ket 520
Chandler 503
Singapore 420
Boardman 308
Santa Clara 307
Medford 291
Princeton 291
Hong Kong 263
Altamura 193
Wilmington 180
Redmond 169
Lawrence 155
Ann Arbor 96
Perugia 93
Saint Petersburg 91
Beijing 64
Vienna 53
Norwalk 51
Ashburn 49
Helsinki 36
Andover 34
San Paolo di Civitate 32
Timisoara 28
Kraków 27
Moscow 24
Seoul 23
Den Haag 17
Jacksonville 16
Los Angeles 15
Munich 15
Milan 14
Redwood City 14
Brussels 13
Houston 12
Ottawa 12
Rome 12
Shanghai 11
Guangzhou 9
New York 8
Izmir 7
Tokyo 7
Busto Arsizio 6
Dallas 6
Frankfurt Am Main 6
Nanning 6
Winnipeg 6
Montefano 5
Nanjing 5
Petaling Jaya 5
Rocca Di Papa 5
Saint Louis 5
Bratislava 4
Brno 4
Lausanne 4
Shenzhen 4
Woodbridge 4
Amsterdam 3
Bologna 3
Capannori 3
Central 3
Des Moines 3
Fairfield 3
Falkenstein 3
Lappeenranta 3
Tavagnacco 3
Ancona 2
Cambridge 2
Changsha 2
Chicago 2
Cortona 2
Florence 2
Gimhae 2
Hamburg 2
Hebei 2
Kiev 2
Mississauga 2
Monmouth Junction 2
Pars-lès-Romilly 2
Phoenix 2
Ravenna 2
Salvador 2
Sciacca 2
Seattle 2
Sondrio 2
West Jordan 2
Zumarraga 2
Abidjan 1
Agnadello 1
Antrodoco 1
Antwerp 1
Atlanta 1
Baotou 1
Boston 1
Brescia 1
Caen 1
Caprino Bergamasco 1
Cattolica 1
Cesena 1
Totale 6.424
Nome #
Beneficial effect of Crocus sativus stigma extract in amyloid-beta degradation by monocytes from sporadic Alzheimer's disease patients 94
Clinical and genetic study of an Italian family with complicated hereditary spastic paraplegia and Alzheimer's disease 87
COX inhibitors and bone: A safer impact on osteoblasts by NO-releasing NSAIDs 87
Lesser motor disability in adulthood: A ten-year follow-up of a dyskinetic patient with ADCY5 mutation 82
miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease 77
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 72
Activity levels of a beta1,6 N-acetylglucosaminyltransferase in lymphomonocytes from multiple sclerosis patients 68
Caspase 3 activation and PARP cleavage in lymphocytes from newborn babies of diabetic mothers with unbalanced glycaemic control 67
ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease 67
Spastic paraplegia type 4: a novel SPAST splice site donor mutation and expansion of the phenotype variability 67
Recurrent de novo missense variant E210K in UBTF causes juvenile dystonia-parkinsonism 67
Beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I 66
Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients 63
Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability 63
Crocus sativus L. stigma extract improves amyloid-β degradation mediated by Cathepsin B in monocytes from Alzheimer’s Disease patients 62
ALS phenotypes with mutations in SPG11 61
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms 60
Acid glycohydrolase activities in lymphomonocyte plasma- membranes of patients with multiple sclerosis 59
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study 59
HSP-SPG5A/CYP7B1: unusual clinical and genetic characteristics in an Indian family 59
SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response 58
Haploinsufficiency of KMT2B causes myoclonus-dystonia with impaired psychomotor ability 56
Clinical and molecular profile of a Japanese cohort of patients with dyskinesia 56
A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4) 55
Acanthocytosis as a predisposing factor for non-ketotic hyperglycaemia induced chorea-ballism 55
Clinico-genetic study of two Japanese pedigrees with hereditary spastic paraparesis and Alzheimer’s disease 55
Neuronal inclusion formation and axonal degeneration in mutant TFG transgenic mice 55
Clinical and genetic features of a large cohort of Italian SPG4 patients from the D.A.I.S.Y. collaborative network 55
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis 54
Hereditary spastic paraplegia and Alzheimer’s disease: clinical and genetic study of a Brazilian family 54
Nano- from nature to nurture: A comprehensive review on facets, trends, perspectives and sustainability of nanotechnology in the food sector 54
Choreoathetosis, dystonia, and myoclonus in 3 siblings with autosomal recessive spinocerebellar ataxia type 16 53
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis 53
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 53
A novel AIFM1 missense mutation in a Japanese patient with ataxic sensory neuronopathy and hearing impairment 53
Cathepsin D expression and regulation in fibroblasts from Alzheimer’s disease patients 52
Active secretion of lysosomal glycohydrolases by activated human platelets “in vivo” studies on lysosomal release and molecular mechanisms regulating their secretion 52
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34(+) hematopoietic stem cells of relapsing-remitting multiple sclerosis patients 51
Spastic paraplegia type 4: a novel SPAST splice site donor mutation and expansion of the phenotype variability 51
A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V) 50
Clinical and genetic study of a Japanese family with complicated hereditary spastic paraplegia and Alzheimer's disease 49
Regulation of lysosomal enzymes expression in fibroblasts from Alzheimer’s disease patients 48
Search for new genes causing dementia: targets for novel diagnostics and therapeutics 48
Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease 48
Molecular epidemiology of dystonia in Japan 48
A new SPG4/SPAST mutation in an Italian family with hereditary spastic paraplegia and Alzheimer's disease 48
Evaluation of swallowing in patients with hereditary spastic paraplegias 48
Therapy with drug product AZD-103 may ease Alzheimer's disease 47
Apolipoprotein E 3/2 genotype is associated with early onset cognitive dysfunction in SLE 47
Differential regulation of lysosomal enzymes in fibroblasts from Alzheimer’s disease patients 47
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE 47
Identification of ALS5/SPG11/KIAA1840 Mutations in Patients with Autosomal Recessive Form of Charcot-Marie-Tooth Disease Type 2 46
a-D-Mannosidases in fibroblasts from patients with Alzheimer’s disease 46
Association study of the 5-HT6 receptor gene in Alzheimer’s disease 46
A novel compound heterozygous TH mutation in a Japanese case of dopa-responsive dystonia with mild clinical course 46
Cathepsin B and L are down-regulated in fibroblasts from Alzheimer’s disease patients 45
Lysosomal proteases cathepsin D, B, and L are down-regulated in fibroblasts from Alzheimer’s disease patients 45
SPG11 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease 45
Hereditary spastic paraplegia type 31: A novel splice site donor mutation and intra-familial phenotypic variability 45
Alzheimer’s disease with relevant vascular lesions: a clinical re-evaluation of proteomics 44
Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease 44
Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation 44
Impairment of lysosomal system in neurodegenerative diseases 44
Cathepsin D expression is decreased in Alzheimer's disease fibroblasts 44
Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis 44
Lack of association between Alzheimer's disease and the promoter region polymorphisms of the nicastrin gene 43
Absence of association between APOA1 polymorphism and Alzheimer’s disease 42
Characterization of hMENA gene 42
Non-replication of association between MAPT-SNCA synergistical interaction and susceptibility to Parkinson's disease in a southern European population 42
Cathepsin D expression and processing in fibroblasts from Alzheimer’s disease patients 42
Hereditary Spastic Paraplegia Type 4 (SPG4): A Clinico-Genetic Study in a Large Cohort of Patients with Spastic Paraplegia 41
Hexosaminidase in Trichinella spiralis is a single protein with alpha- and beta-subunits catalytic activities 41
a-D-Mannosidases in patients with familial Alzheimer’s disease 41
Cloning of human MENA gene 41
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 41
Transmission Jeopardy of Adenomatosis Polyposis Coli and Methylenetetrahydrofolate Reductase in Colorectal Cancer 41
Spatacsina mutata in una forma di sclerosi laterale amiotrofica 40
Therapy with drug product AZD-103 may ease Alzheimer's disease 40
Hereditary spastic paraplegia type 31: a novel splice site donor mutation and intra-familial phenotypic variability 40
Phenotype variability and allelic heterogeneity in KMT2B-Associated disease 40
Cohort profile of the Japan Dystonia Consortium: Genetic diagnosis and characteristics of movement disorders in Japan 40
Genetics of Alzheimer’s disease 39
VWA3B mutated in a family with cerebellar ataxia with psychomotor retardation 39
Influence of Ras up-regulation on lysosomal enzymes expression 39
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 39
Absence of linkage between familial amyotrophic lateral sclerosis and copper chaperone for the superoxide dismutase (CCS) gene locus in two Italian pedigrees 39
Differential regulation of lysosomal enzymes in fibroblasts from patients with Alzheimer’s disease 39
A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts 39
miR128 up-regulation correlates with impaired Amyloid-β42 degradation in monocytes of patients with sporadic Alzheimer’s disease 39
Clinical and genetic studies in hereditary spastic paraplegia 38
Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: A novel mutation in the SPG11 gene and further evidence for genetic heterogeneity 38
Association of APOE ε4 allele with vascular dementia in Italian population 38
Expression and processing of cathepsin D in fibroblasts of patients with Alzheimer’s disease 38
Cathepsin D, B and L are down-regulated in fibroblasts from Alzheimer’s disease patients 38
Clinical and genetic research in a large Ukrainian family with autosomal recessive hereditary spastic paraplegia 37
A homozygous mutation of VWA3B causes cerebellar ataxia with intellectual disability 37
Polymorphisms in the MAPT gene and risk of Parkinson disease in a Greek population: A case-control study 37
Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia-parkinsonism 37
Silver syndrome variant of hereditary spastic paraplegia: identification of a novel locus 37
Clinical and genetic findings of two Italian kindreds with Silver Syndrome 37
Totale 4.996
Categoria #
all - tutte 55.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020171 0 0 0 0 0 7 15 19 20 68 21 21
2020/20211.333 48 2 7 37 571 21 59 17 16 14 15 526
2021/20222.168 19 406 171 20 167 18 59 662 25 53 267 301
2022/20232.592 300 489 34 70 158 128 1 89 1.238 9 54 22
2023/2024993 45 88 49 23 3 12 251 27 21 52 219 203
2024/20251.091 21 329 73 61 338 269 0 0 0 0 0 0
Totale 9.897